Plasmonix, the bioanalysis technology company that was one of the first companies to receive a (small) piece of the $84 million InvestMaryland fund, plans to launch its first product early this year, reports BmoreMedia.
The product, QuantArray, “has various applications in performing assays, a test that analyzes components, and enhances luminescent signals hundred-fold over conventional methods,” according to BmoreMedia.
At the heart of Plasmonix’s business is metal-enhanced fluorescence, which is a process used to detect cells in medical and clinical research. The technology behind Plasmonix’s business has applications not only in the medical field, but also in cosmetics, paints and lighting.
Founded in 2009, Plasmonix occupies space in UMBC‘s Research and Technology Park, and has four employees now.
Join our growing Slack community
Join 5,000 tech professionals and entrepreneurs in our community Slack today!
Donate to the Journalism Fund
Your support powers our independent journalism. Unlike most business-media outlets, we don’t have a paywall. Instead, we count on your personal and organizational contributions.
The case for storytelling: Want your region’s tech scene to grow? Start with a story, new data says
When global tech association CompTIA spun off its nonprofit arm, the TechGirlz curriculum went dark
The fall of giants: How technical leadership gaps broke three once-mighty tech companies
